Historical salary details - Dr. Robert J. Spiegel, F.A.C.P.,M.D., Vice Chairman of the Board, Cyclacel Pharmaceuticals Inc
Dr. Robert J. Spiegel, F.A.C.P.,M.D. is the Vice Chairman of the Board of Cyclacel Pharmaceuticals Inc.
Dr. Robert J. Spiegel, F.A.C.P.,M.D.
Vice Chairman of the Board
-
Gross Remuneration
-
Current Company
Cyclacel Pharmaceuticals Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Cyclacel Pharmaceuticals Inc | Vice Chairman of the Board | - | - |
| 2024 | Geron Corp. | Independent Director | 583.3 K | - |
| 2024 | Cyclacel Pharmaceuticals Inc | Vice Chairman of the Board | 84.5 K | -27.1 % |
| 2024 | RenovoRx Inc | Independent Director | - | - |
| 2024 | Capstone Holding Corp | Director | - | - |
| 2023 | RenovoRx Inc | Independent Director | 173.7 K | - |
| 2023 | Cyclacel Pharmaceuticals Inc | Vice Chairman of the Board | 116.0 K | - |
| 2023 | Geron Corp. | Independent Director | - | - |
| 2022 | Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10 | Vice Chairman of the Board | 130.8 K | - |
| 2022 | Geron Corp. | Independent Director | - | - |
| 2022 | RenovoRx Inc | Independent Director | - | - |
| 2021 | Geron Corp. | Independent Director | 132.3 K | -5.0 % |
| 2021 | Cyclacel Pharmaceuticals Inc | Vice Chairman of the Board | 126.8 K | 54.8 % |
| 2020 | Geron Corp. | Independent Director | 139.2 K | 9.7 % |
| 2020 | Cyclacel Pharmaceuticals Inc | Vice Chairman of the Board | 81.9 K | 22.7 % |
| 2019 | Geron Corp. | Independent Director | 126.9 K | -42.8 % |
| 2019 | Cyclacel Pharmaceuticals Inc | Independent Director | 66.7 K | 141.6 % |
| 2019 | PDS Biotechnology Corporation | - | 13.7 K | -84.7 % |
| 2019 | PDS Biotechnology Corporation | Independent Director | - | - |
| 2018 | Geron Corp. | Independent Director | 221.9 K | 46.3 % |
| 2018 | PDS Biotechnology Corporation | Independent Director | 89.3 K | -41.9 % |
| 2018 | Cyclacel Pharmaceuticals Inc | Independent Director | 27.6 K | - |
| 2017 | PDS Biotechnology Corporation | Independent Director | 153.8 K | 18.2 % |
| 2017 | Geron Corp. | Independent Director | 151.6 K | -2.3 % |
| 2016 | Geron Corp. | Independent Director | 155.3 K | 1.0 % |
| 2016 | PDS Biotechnology Corporation | Independent Director | 130.1 K | -34.9 % |
| 2015 | PDS Biotechnology Corporation | Independent Director | 200.0 K | 783.7 % |
| 2015 | Geron Corp. | Independent Director | 153.7 K | 44.4 % |
| 2014 | Geron Corp. | Independent Director | 106.5 K | 29.2 % |
| 2014 | PDS Biotechnology Corporation | Independent Director | 22.6 K | - |
| 2013 | Geron Corp. | Independent Director | 82.4 K | -10.8 % |
| 2012 | Geron Corp. | Independent Director | 92.3 K | -26.9 % |
| 2011 | Geron Corp. | Independent Director | 126.4 K | -32.6 % |
| 2010 | Geron Corp. | Director | 187.5 K | - |